SUBSCRIBE
SUBSCRIBE

Texas

LATEST FROM BIOSPACE
Drug Development
Baylor College of Medicine Led Research Finds Asthma Risk Increases in Children Treated for HIV
July 3, 2008
 · 
1 min read
Drug Development
Texas A&M University Study Finds Watermelon Has Effects Similar to Viagra
July 3, 2008
 · 
1 min read
Drug Development
UT Southwestern Medical Center Study Warns Resuscitation Technique after Brain Injury may do More Harm than Good
July 2, 2008
 · 
1 min read
Lone Star Bio
Self-Cleaning Membrane Shrugs Off Unwanted Cells in Texas A&M University Study
June 27, 2008
 · 
1 min read
Lone Star Bio
Laser Surgery Probe Targets Individual Cancer Cells in University of Texas Study
June 26, 2008
 · 
1 min read
Biotech Bay
Small is Beautiful -- BioPharm Executive
June 25, 2008
 · 
2 min read
BioCapital
Protein Linked to Alzheimer’s Disease Also Has Role in HIV Progression, Gladstone Institute, University of California, San Francisco (UCSF), University of Texas Health Science Center, and Uniformed Services University Study Finds
June 18, 2008
 · 
1 min read
Lone Star Bio
Nanotechnology, Biomolecules and Light Unite To ‘Cook’ Cancer Cells at UT Southwestern Medical Center
June 18, 2008
 · 
1 min read
Drug Development
New Compound May Treat Serious Bacterial Diarrhea, University of Texas Scientists Say
June 17, 2008
 · 
1 min read
Drug Development
Patch Vaccine Holds Off Traveller’s Diarrhea: University of Texas Study
June 12, 2008
 · 
1 min read
Load More
PRESS RELEASES
Press Releases
Colossal Foundation and University of Tasmania Partner to Combat Devil Facial Tumour Disease with Vaccines and Gene Editing
July 1, 2026
 · 
11 min read
Press Releases
Vizient Forecasts 20% Growth in Outpatient Care, 7% in Inpatient Care
June 30, 2026
 · 
3 min read
Press Releases
AustinPx Expands KinetiSol™ Technology Commercial Access through Thermo Fisher Scientific Collaboration
June 30, 2026
 · 
4 min read
Press Releases
FibroBiologics to Participate in Fireside Chat at H.C. Wainwright 4th Annual Cell Therapy Virtual Conference
June 30, 2026
 · 
1 min read
Press Releases
Moleculin Reports Positive Phase 2/3 MIRACLE Interim Results, With Annamycin Complete Remission Rates 3-fold Greater than Control
June 30, 2026
 · 
9 min read
Press Releases
Plus Therapeutics Provides Mid-Year Business Update Including Corporate Rebranding
June 30, 2026
 · 
10 min read
Press Releases
FibroBiologics Announces Closing of up to $9.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
June 30, 2026
 · 
5 min read
Press Releases
Texas Biomed and Flyttr partner to advance next-generation solutions for the invasive New World screwworm
June 29, 2026
 · 
3 min read
Press Releases
Natera and Aveta Biomics Announce Strategic Partnership Supporting Global Phase 3 Registrational Trial of APG-157 in Head and Neck Cancer
June 29, 2026
 · 
6 min read
Press Releases
Decoy Therapeutics, Inc. Announces Up to $21 Million Private Placement Financing
June 28, 2026
 · 
5 min read
Load More